Navigation Links
Sony Announces World's First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
Date:7/11/2012

PARK RIDGE, N.J., July 11, 2012 /PRNewswire/ -- Sony Electronics is announcing the world's first medical-grade monitor, model PVM-2551MD, based on Organic Light-Emitting Diode (OLED) technology. The new 25-inch monitor, which recently received FDA 510(k) clearance, is expected to deliver significant benefits for a variety of surgical procedures and combines all the noted advantages of Sony's OLED technology -- true-to-life color reproduction, high resolution, and virtually no motion blur. 

(Photo: http://photos.prnewswire.com/prnh/20120711/NY38634)

"Already showing tremendous advantages for surgeons in other parts of the world, the new Sony OLED monitor will now enhance surgical viewing  in the U.S., and become the 'must have' medical display," said George Santanello, general manager, Sony Medical Systems Division.  "A number of Sony's key technology resellers and integrators have already evaluated the display and noted the significant benefits of OLED versus traditional LCD, so we're excited about getting the product into operating rooms across the country."

The majority of surgeons, both in and outside the U.S., who were asked to evaluate Sony's OLED monitors, reported that they prefer OLED's advanced technology for its stability of color imaging and high quality contrast. This technology is expected to set a new standard for medical displays, particularly for applications such as endoscopy, arthroscopy, laparoscopy, and thoracoscopy, as well as general surgery procedures.

Sony's OLED technology is already extremely successful in a range of commercial applications such as critical reference monitoring for video production, with more than 10,000 units delivered worldwide. Now the company expects to see the same rapid adoption by the medical industry.

With its much quicker response time than LCD, one of the greatest advantages of the OLED monitor is its ability to display quick motion with virtually no blur. Additionally, the monitor incorporates Sony's revolutionary TRIMASTER EL technology (EL standing for electroluminescence), enabling it to achieve pure black, faithful to the source signal. By providing superb color reproduction, especially for dark images, surgeons can observe very subtle details such as the faint color difference between various tissues and blood vessels.  This ability to achieve true-to-life color reproduction and reduced blur is expected to support quicker, more confident decision making for surgeons which is ultimately best for patients.

Other features and advantages of the OLED monitor include the following:

  • Self-luminous, emitting no black when displaying images and displaying a high level of contrast
  • 10-bit signal processing
  • Extremely slim and light-weight design
  • Reduced power consumption requirements for increased energy efficiency.

The Sony OLED medical-grade monitor, PVM-2551MD, is currently available for sale with pricing available upon request.


'/>"/>
SOURCE Sony Electronics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
2. Angioslide Announces First Successful Below-The-Knee Procedures in the US
3. CryoLife Announces Release Date and Teleconference Call Details for 2012 Second Quarter Financial Results
4. PTC Therapeutics Announces Achievement of Major Milestone in Wellcome Trust BMI1 Collaboration
5. Lilly Announces Pomaglumetad Methionil Did Not Meet Primary Endpoint of Clinical Study
6. Genova Diagnostics, Inc. Announces the Acquisition of Metametrix, Inc.
7. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
8. Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
9. Elsevier Announces New Editor-In-Chief for Neurobiology of Learning and Memory
10. Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
11. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
(Date:7/6/2017)... CINCINNATI , July 6, 2017 ThriveRx, the nutrition division ... and their families to thrive on nutrition support. To celebrate ... The new site has a fresh new look with improved organization to ... ... ...
Breaking Medicine Technology:
(Date:7/22/2017)... ... July 22, 2017 , ... More than ... of patients not requiring pain medication after three months post-operatively. However, researchers presenting ... Meeting today in Toronto, Ontario, Canada found that those patients who were filling ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern Georgie provider ... in a community wide charity event with the goal of bringing in support for ... woman who lives with epilepsy, recently launched a charity campaign of her own by ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... Philadelphia and Theater of Witness , was awarded a $300,000 grant ... humanities program which fosters empathy, comfort with ambiguity and the recognition of one’s ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated ... life a decade after surgery, though activity levels decline over time. The study, ...
Breaking Medicine News(10 mins):